Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The cancer genome.

Literature DB >> 19360079

The cancer genome.

Michael R Stratton¹, Peter J Campbell, P Andrew Futreal.

Abstract

All cancers arise as a result of changes that have occurred in the DNA sequence of the genomes of cancer cells. Over the past quarter of a century much has been learnt about these mutations and the abnormal genes that operate in human cancers. We are now, however, moving into an era in which it will be possible to obtain the complete DNA sequence of large numbers of cancer genomes. These studies will provide us with a detailed and comprehensive perspective on how individual cancers have developed.

Entities: CellLine Chemical Disease Gene Mutation Species

Mesh：

Year: 2009 PMID： 19360079 PMCID： PMC2821689 DOI： 10.1038/nature07943

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962

55 in total

1. Mutational analysis of the tyrosine kinome in colorectal cancers.

Authors: Alberto Bardelli; D Williams Parsons; Natalie Silliman; Janine Ptak; Steve Szabo; Saurabh Saha; Sanford Markowitz; James K V Willson; Giovanni Parmigiani; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal: Science Date: 2003-05-09 Impact factor: 47.728

2. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid.

Authors: J D WATSON; F H CRICK
Journal: Nature Date: 1953-04-25 Impact factor: 49.962

3. Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution.

Authors: Graham R Bignell; Thomas Santarius; Jessica C M Pole; Adam P Butler; Janet Perry; Erin Pleasance; Chris Greenman; Andrew Menzies; Sheila Taylor; Sarah Edkins; Peter Campbell; Michael Quail; Bob Plumb; Lucy Matthews; Kirsten McLay; Paul A W Edwards; Jane Rogers; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal: Genome Res Date: 2007-08-03 Impact factor: 9.043

4. Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing.

Authors: Roman K Thomas; Elizabeth Nickerson; Jan F Simons; Pasi A Jänne; Torstein Tengs; Yuki Yuza; Levi A Garraway; Thomas LaFramboise; Jeffrey C Lee; Kinjal Shah; Keith O'Neill; Hidefumi Sasaki; Neal Lindeman; Kwok-Kin Wong; Ana M Borras; Edward J Gutmann; Konstantin H Dragnev; Ralph DeBiasi; Tzu-Hsiu Chen; Karen A Glatt; Heidi Greulich; Brian Desany; Christine K Lubeski; William Brockman; Pablo Alvarez; Stephen K Hutchison; J H Leamon; Michael T Ronan; Gregory S Turenchalk; Michael Egholm; William R Sellers; Jonathan M Rothberg; Matthew Meyerson
Journal: Nat Med Date: 2006-06-25 Impact factor: 53.440

5. STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors: O T Avery; C M Macleod; M McCarty
Journal: J Exp Med Date: 1944-02-01 Impact factor: 14.307

Review 6. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors: Gary L Johnson; Razvan Lapadat
Journal: Science Date: 2002-12-06 Impact factor: 47.728

7. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Authors: Ross L Levine; Martha Wadleigh; Jan Cools; Benjamin L Ebert; Gerlinde Wernig; Brian J P Huntly; Titus J Boggon; Iwona Wlodarska; Jennifer J Clark; Sandra Moore; Jennifer Adelsperger; Sumin Koo; Jeffrey C Lee; Stacey Gabriel; Thomas Mercher; Alan D'Andrea; Stefan Fröhling; Konstanze Döhner; Peter Marynen; Peter Vandenberghe; Ruben A Mesa; Ayalew Tefferi; James D Griffin; Michael J Eck; William R Sellers; Matthew Meyerson; Todd R Golub; Stephanie J Lee; D Gary Gilliland
Journal: Cancer Cell Date: 2005-04 Impact factor: 31.743

8. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.

Authors: Chris Hunter; Raffaella Smith; Daniel P Cahill; Philip Stephens; Claire Stevens; Jon Teague; Chris Greenman; Sarah Edkins; Graham Bignell; Helen Davies; Sarah O'Meara; Adrian Parker; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Adam Butler; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; Andy Jenkinson; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; David Richardson; Rebecca Shepherd; Alexandra Small; Helen Solomon; Calli Tofts; Jennifer Varian; Sofie West; Sara Widaa; Andy Yates; Douglas F Easton; Gregory Riggins; Jennifer E Roy; Kymberly K Levine; Wolf Mueller; Tracy T Batchelor; David N Louis; Michael R Stratton; P Andrew Futreal; Richard Wooster
Journal: Cancer Res Date: 2006-04-15 Impact factor: 12.701

Review 9. Viruses and tumours--an update.

Authors: Simon J Talbot; Dorothy H Crawford
Journal: Eur J Cancer Date: 2004-09 Impact factor: 9.162

Review 10. Targeted cancer therapy.

Authors: Charles Sawyers
Journal: Nature Date: 2004-11-18 Impact factor: 49.962

1217 in total

Review 1. Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors.

Authors: Toshifumi Wakai; Pankaj Prasoon; Yuki Hirose; Yoshifumi Shimada; Hiroshi Ichikawa; Masayuki Nagahashi
Journal: Int J Clin Oncol Date: 2018-12-04 Impact factor: 3.402

2. Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance.

Authors: Shawna Mae Hengel; Euan Murray; Simon Langdon; Larry Hayward; Jean O'Donoghue; Alexandre Panchaud; Ted Hupp; David R Goodlett
Journal: J Proteome Res Date: 2011-09-21 Impact factor: 4.466

Review 3. Tumor hypoxia and genetic alterations in sporadic cancers.

Authors: Minoru Koi; Clement R Boland
Journal: J Obstet Gynaecol Res Date: 2011-01-27 Impact factor: 1.730

4. Endogenous DNA replication stress results in expansion of dNTP pools and a mutator phenotype.

Authors: Marta B Davidson; Yuki Katou; Andrea Keszthelyi; Tina L Sing; Tian Xia; Jiongwen Ou; Jessica A Vaisica; Neroshan Thevakumaran; Lisette Marjavaara; Chad L Myers; Andrei Chabes; Katsuhiko Shirahige; Grant W Brown
Journal: EMBO J Date: 2012-01-10 Impact factor: 11.598

Review 5. Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities.

Authors: Xi Lin; Wenxue Tang; Shoeb Ahmad; Jingqiao Lu; Candice C Colby; Jason Zhu; Qing Yu
Journal: Hear Res Date: 2012-01-14 Impact factor: 3.208

Review 6. An evolutionary perspective on field cancerization.

Authors: Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal: Nat Rev Cancer Date: 2017-12-08 Impact factor: 60.716

7. Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia.

Authors: Thirunavukkarasu Velusamy; Nallasivam Palanisamy; Shanker Kalyana-Sundaram; Anagh Anant Sahasrabuddhe; Christopher A Maher; Daniel R Robinson; David W Bahler; Timothy T Cornell; Thomas E Wilson; Megan S Lim; Arul M Chinnaiyan; Kojo S J Elenitoba-Johnson
Journal: Proc Natl Acad Sci U S A Date: 2013-02-04 Impact factor: 11.205